Seeing Is Believing
with an average price target of $246310.24. This is a potential upside of $246305.63 (5342855.31%) from yesterday's end of day stock price of $4.61.
ReShape Lifesciences's activity chart (see below) currently has 2 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 1.25 days.
Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 26-May-2022. First documented stock forecast 31-Oct-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2 years 6 months 22 days ago
(26-May-2022)
1/2 (50%)
$17719 (103.74%)
5
Buy
$400
2 years 8 months 19 days ago
(29-Mar-2022)
0/1 (0%)
$243.5 (155.59%)
Hold
5 years 6 months 26 days ago
(22-May-2019)
0/2 (0%)
$900210 (101.74%)
Buy
5 years 9 months 23 days ago
(25-Feb-2019)
0/2 (0%)
$67050 (27.04%)
What is RSLS (ReShape Lifesciences) average time for price targets to be met?
Which analyst has the current highest performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?
Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?
Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?